[20220218]IF12050_联邦支持国内2019冠状病毒疾病检测可用性.pdf

https:/crsreports.congress.gov February 18, 2022Federal Support for Domestic COVID-19 Test AvailabilityIn January 2022, the White House launched several actions to boost the availability of Coronavirus Disease 2019 (COVID-19) tests to the general public, including the distribution of rapid antigen tests to individuals free of cost, enhanced testing initiatives in K-12 schools, and expansion of community testing options. This In Focus covers the federal funding sources, activities, and mechanisms that support domestic COVID-19 test availability as of the date of publication. As defined here, activities to support COVID-19 test availability include (1) the purchase, manufacture, and distribution of tests and related supplies, and (2) support for community and institution-based (e.g., school) testing programs. This In Focus does not address funding or financing for testing-related research and development, regulation, provider reimbursement, health service delivery, or health insurance. Appropriations The list below provides a general overview of major COVID-19 relief appropriations that support domestic COVID-19 test availability, but it is not exhaustive. The following Department o